Zantac Lawsuit: Status, Eligibility, & Settlements - Drugwatch
网页2024年9月3日 · People who took Zantac made with ranitidine and developed cancer filed lawsuits after manufacturers issued ranitidine and Zantac recalls for the potential risk of cancer. FDA found Zantac’s active ingredient ranitidine contained N-Nitrosodimethylamine (‘NDMA’) — a probable human carcinogen.
GSK shares tumble after Delaware court ruling on Zantac - Financial Times
网页2024年6月3日 · GSK shares dropped almost 10 per cent on Monday after a ruling from a Delaware judge left the UK drugmaker exposed to US jury trials over its allegedly carcinogenic heartburn treatment Zantac.
GSK asks to appeal Delaware ruling allowing Zantac cases to go …
网页2024年6月10日 · GSK and other drugmakers on Monday asked a Delaware court for permission to appeal a ruling allowing more than 70,000 lawsuits claiming that heartburn drug Zantac causes cancer to go forward.
Boehringer Ingelheim Faces Second Hung Jury in Chicago Zantac …
网页6 天之前 · By Brendan Pierson. (Reuters) -The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree ...
GSK settles two California lawsuits related to heartburn drug Zantac
网页6 天之前 · Sept 18 (Reuters) - British drugmaker GSK (GSK.L) said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does ...
GSK set to face jury trials over heartburn drug Zantac - Financial Times
网页2024年6月1日 · The ruling by Judge Vivian Medinilla means that scientific experts will be able to testify before a jury that there is a link between the plaintiffs’ cancers and their exposure to NDMA, a probable...
Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by …
网页2024年7月1日 · A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward.
Victory for drugmakers GSK and Boehringer in $640 million Zantac …
网页2024年5月24日 · Drugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a woman’s claim that the blockbuster heartburn drug Zantac caused her cancer, handing the companies a win in ...
Pfizer offers up to $250mn to settle thousands of Zantac cancer …
网页2024年5月16日 · Pfizer has agreed to pay up to $250mn to settle more than 10,000 US lawsuits over cancer risks associated with its now-discontinued heartburn drug Zantac, according to people familiar with the...
Boehringer, GSK, Pfizer Still Face Zantac Cases Despite Mistrial
网页5 天之前 · Zantac manufacturers still face federal, state cases. An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but won’t be the last. Illinois resident Ronald Kimbrow in 2023 sued Boehringer Ingelheim Pharmaceuticals Inc., GlaxoSmithKline Holdings, Pfizer Inc., Walgreens Boots ...